Cold Plasma Market Growth Drivers and Challenges:
Growth Drivers
- Growing Geriatric Population - According to the World Health Organization, one in six individuals on the planet would be 60 or older by 2030. By this point, there are projected to be 1.4 billion people over the age of 60, up from 1 billion in 2020. With the growing geriatric population, the prevalence of disease is also growing among them. They are more prevalent to various fungal infection such as skin and nail infection. Elderly adults have less blood flow and are exposed to the fungus for longer periods of time. The likelihood of getting the condition is further increased by a history of skin problems including psoriasis and athlete's foot. Hence, the demand for cold plasma therapy is more among them.
- Rise in Prevalence of Cancer - In 2020, it is predicted that there would be 1,806,590 new cancer diagnoses in the United States, and 606,520 cancer-related deaths.
- Surge in Number of People Suffering from Leg Ulcers - In the UK, venous leg ulcers are anticipated to afflict about 2 in 500 individuals by 2023.
- Growth in Healthcare Expenditure - The amount spent on healthcare in the United States in 2021 increased by around 3%, reaching over USD 3 trillion, or roughly USD 12,913 per person.
- Upsurge in Spread of Infection through Medical Equipment - Several bacterial isolates were found to be colonizing 88% of the medical equipment in Sub-Saharan Africa in 2020. Medical device-related infections are incredibly prevalent and challenging to cure. If exposed to bacteria, heart devices, pacemakers, wires, or defibrillators may become infected. Pain, redness, nauseousness, or sore-related discharge are all potential signs. Hence, the demand for cold plasma is estimated to increase in order to disinfect the equipment.
Challenges
- Requirement of High Capital Investment - Companies always evaluate the advantages of a technology in terms of their budget, investment, and the amount of time needed to recoup that expenditure. The equipment required for cold plasma coating technologies, such as vacuum equipment, is expensive and requires specialized operating conditions, such as low temperatures and controlled vacuum conditions, in order to function. As a result, cold plasma coating technologies require a significant investment in capital. Hence, this factor is estimated to hinder the growth of the market.
- Lack of Commercialization of Cold Plasma
- Side Effects of Cold Plasma on Humans
Cold Plasma Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
13.5% |
|
Base Year Market Size (2025) |
USD 2.44 billion |
|
Forecast Year Market Size (2035) |
USD 8.66 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cold plasma is assessed at USD 2.74 billion.
The global cold plasma market size was valued at over USD 2.44 billion in 2025 and is expected to expand at a CAGR of over 13.5%, surpassing USD 8.66 billion revenue by 2035.
North America cold plasma market will hold over 40.9% share by 2035, rising healthcare expenditure, cancer prevalence, and adoption of cold atmospheric plasma technology.
Key players in the market include Apyx Medical Corporation, Nordson Corporation, Adtec RF, P2i Limited, Relyon Plasma GmbH, Henniker Plasma, Enercon Industries Corporation, AcXys Plasma Technologies, Plasmatreat GmbH, Tantec A/S.
